{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:43:13Z","timestamp":1774352593536,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88420-7","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T08:47:34Z","timestamp":1739609254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of dietary live microbes intake on a newly proposed classification system for steatotic liver disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhikun","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingtao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoxian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"3","key":"88420_CR1","first-page":"e93","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79(3), e93\u2013e94 (2023).","journal-title":"J. Hepatol."},{"issue":"3","key":"88420_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan, W. K. et al. Metabolic dysfunction-associated steatotic liver disease (MASLD): A state-of-the-art review. J. Obes. Metab. Syndr. 32(3), 197\u2013213 (2023).","journal-title":"J. Obes. Metab. Syndr."},{"issue":"5","key":"88420_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/hep.32552","volume":"76","author":"LA van Kleef","year":"2022","unstructured":"van Kleef, L. A. & de Knegt, R. J. The transition from NAFLD to MAFLD: One size still does not fit all-Time for a tailored approach?. Hepatology. 76(5), 1243\u20131245 (2022).","journal-title":"Hepatology."},{"issue":"5","key":"88420_CR4","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 136(5), E359\u2013E386 (2015).","journal-title":"Int. J. Cancer."},{"issue":"10","key":"88420_CR5","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","volume":"71","author":"JF Dufour","year":"2022","unstructured":"Dufour, J. F. et al. Current therapies and new developments in NASH. Gut. 71(10), 2123\u20132134 (2022).","journal-title":"Gut."},{"key":"88420_CR6","doi-asserted-by":"publisher","first-page":"111190","DOI":"10.1016\/j.envres.2021.111190","volume":"197","author":"X Wang","year":"2021","unstructured":"Wang, X., Seo, Y. A. & Park, S. K. Serum selenium and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National health and nutrition examination survey (NHANES) 2011\u20132016. Environ. Res. 197, 111190 (2021).","journal-title":"Environ. Res."},{"issue":"15","key":"88420_CR7","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.3390\/ijms21155214","volume":"21","author":"J Chen","year":"2020","unstructured":"Chen, J. & Vitetta, L. Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications. Int. J. Mol. Sci. 21(15), 5214 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"88420_CR8","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/nu11081712","volume":"11","author":"Y Ji","year":"2019","unstructured":"Ji, Y., Yin, Y., Li, Z. & Zhang, W. Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD). Nutrients. 11(8), 1712 (2019).","journal-title":"Nutrients."},{"issue":"17","key":"88420_CR9","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.3390\/foods11172703","volume":"11","author":"MK Jeong","year":"2022","unstructured":"Jeong, M. K. et al. Food and gut microbiota-derived metabolites in nonalcoholic fatty liver disease. Foods. 11(17), 2703 (2022).","journal-title":"Foods."},{"issue":"2","key":"88420_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","volume":"28","author":"S Lang","year":"2020","unstructured":"Lang, S. & Schnabl, B. Microbiota and fatty liver disease-the known, the unknown, and the future. Cell Host Microbe. 28(2), 233\u2013244 (2020).","journal-title":"Cell Host Microbe."},{"issue":"1","key":"88420_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19(1), 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"88420_CR12","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","volume":"113","author":"EZ Gomaa","year":"2020","unstructured":"Gomaa, E. Z. Human gut microbiota\/microbiome in health and diseases: A review. Antonie Van Leeuwenhoek. 113(12), 2019\u20132040 (2020).","journal-title":"Antonie Van Leeuwenhoek."},{"issue":"5","key":"88420_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/nutrit\/nuaa013","volume":"79","author":"DA Savaiano","year":"2021","unstructured":"Savaiano, D. A. & Hutkins, R. W. Yogurt, cultured fermented milk, and health: A systematic review. Nutr. Rev. 79(5), 599\u2013614 (2021).","journal-title":"Nutr. Rev."},{"issue":"8","key":"88420_CR14","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3390\/nu11081806","volume":"11","author":"E Dimidi","year":"2019","unstructured":"Dimidi, E., Cox, S. R., Rossi, M. & Whelan, K. Fermented foods: Definitions and characteristics, impact on the gut microbiota and effects on gastrointestinal health and disease. Nutrients. 11(8), 1806 (2019).","journal-title":"Nutrients."},{"issue":"7","key":"88420_CR15","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/jn\/nxac074","volume":"152","author":"ML Marco","year":"2022","unstructured":"Marco, M. L. et al. A classification system for defining and estimating dietary intake of live microbes in US adults and children. J Nutr. 152(7), 1729\u20131736 (2022).","journal-title":"J Nutr."},{"key":"88420_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.689084","volume":"8","author":"M Roselli","year":"2021","unstructured":"Roselli, M. et al. Colonization ability and impact on human gut microbiota of foodborne microbes from traditional or probiotic-added fermented foods: A systematic review. Front. Nutr. 8, 689084 (2021).","journal-title":"Front. Nutr."},{"issue":"4","key":"88420_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.tjnut.2023.02.019","volume":"153","author":"C Hill","year":"2023","unstructured":"Hill, C. et al. Positive health outcomes associated with live microbe intake from foods, including fermented foods, assessed using the NHANES database. J. Nutr. 153(4), 1143\u20131149 (2023).","journal-title":"J. Nutr."},{"issue":"8","key":"88420_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson, G. R. et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 14(8), 491\u2013502 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"88420_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1053\/j.gastro.2021.04.037","volume":"161","author":"LE O'Connor","year":"2021","unstructured":"O\u2019Connor, L. E. et al. Nonfood prebiotic, probiotic, and synbiotic use has increased in US adults and children from 1999 to 2018. Gastroenterology. 161(2), 476\u201386.e3 (2021).","journal-title":"Gastroenterology."},{"issue":"3","key":"88420_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41430-019-0497-7","volume":"74","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. Association between habitual yogurt consumption and newly diagnosed non-alcoholic fatty liver disease. Eur. J. Clin. Nutr. 74(3), 491\u2013499 (2020).","journal-title":"Eur. J. Clin. Nutr."},{"key":"88420_CR21","doi-asserted-by":"publisher","first-page":"1334935","DOI":"10.3389\/fnut.2024.1334935","volume":"11","author":"Y Song","year":"2024","unstructured":"Song, Y. et al. Probiotic consumption and hepatic steatosis: Results from the NHANES 2011\u20132016 and Mendelian randomization study. Front. Nutr. 11, 1334935 (2024).","journal-title":"Front. Nutr."},{"issue":"8","key":"88420_CR22","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.numecd.2023.04.018","volume":"33","author":"E Yuzbashian","year":"2023","unstructured":"Yuzbashian, E., Fernando, D. N., Pakseresht, M., Eurich, D. T. & Chan, C. B. Dairy product consumption and risk of non-alcoholic fatty liver disease: A systematic review and meta-analysis of observational studies. Nutr. Metab. Cardiovasc. Dis. 33(8), 1461\u20131471 (2023).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"3","key":"88420_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","volume":"64","author":"F Famouri","year":"2017","unstructured":"Famouri, F., Shariat, Z., Hashemipour, M., Keikha, M. & Kelishadi, R. Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents. J. Pediatr. Gastroenterol. Nutr. 64(3), 413\u2013417 (2017).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"15","key":"88420_CR24","doi-asserted-by":"publisher","first-page":"8805","DOI":"10.3390\/ijms23158805","volume":"23","author":"RZ Carpi","year":"2022","unstructured":"Carpi, R. Z. et al. The effects of probiotics, prebiotics and synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A systematic review. Int. J. Mol. Sci. 23(15), 8805 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"88420_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glad175","author":"H Tang","year":"2023","unstructured":"Tang, H., Zhang, X., Luo, N., Huang, J. & Zhu, Y. Association of dietary live microbes and non-dietary prebiotic\/probiotic intake with cognitive function in older adults: Evidence from NHANES. J. Gerontol. A Biol. Sci. Med. Sci. https:\/\/doi.org\/10.1093\/gerona\/glad175 (2023).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"88420_CR26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","volume":"79","author":"BP Lee","year":"2023","unstructured":"Lee, B. P., Dodge, J. L. & Terrault, N. A. National prevalence estimates for steatotic liver disease and Sub-Classifications using consensus nomenclature. Hepatology. 79(3), 666\u2013673 (2023).","journal-title":"Hepatology."},{"issue":"1","key":"88420_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl, C. E. & Everhart, J. E. Fatty liver indices in the multiethnic United States national health and nutrition examination survey. Aliment Pharmacol. Ther. 41(1), 65\u201376 (2015).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"22","key":"88420_CR28","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.3390\/nu14224908","volume":"14","author":"L Han","year":"2022","unstructured":"Han, L. & Wang, Q. Association of dietary live microbe intake with cardiovascular disease in US Adults: A cross-sectional study of NHANES 2007\u20132018. Nutrients. 14(22), 4908 (2022).","journal-title":"Nutrients."},{"issue":"21","key":"88420_CR29","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.3390\/nu14214505","volume":"14","author":"T Tian","year":"2022","unstructured":"Tian, T. et al. Dietary quality and relationships with metabolic dysfunction-associated fatty liver disease (MAFLD) among United States adults, results from NHANES 2017\u20132018. Nutrients. 14(21), 4505 (2022).","journal-title":"Nutrients."},{"issue":"5","key":"88420_CR30","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1016\/j.jhep.2023.09.023","volume":"80","author":"S Ciardullo","year":"2023","unstructured":"Ciardullo, S. & Perseghin, G. Steatotic liver disease phenotypes in the United States: The impact of alcohol consumption assessment. J. Hepatol. 80(5), e203\u2013e204 (2023).","journal-title":"J. Hepatol."},{"issue":"2","key":"88420_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/apt.15580","volume":"51","author":"JM Paik","year":"2020","unstructured":"Paik, J. M. et al. The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease. Aliment Pharmacol. Ther. 51(2), 291\u2013304 (2020).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"9","key":"88420_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jand.2018.05.021","volume":"118","author":"SM Krebs-Smith","year":"2018","unstructured":"Krebs-Smith, S. M. et al. Update of the healthy eating index: HEI-2015. J Acad Nutr Diet. 118(9), 1591\u20131602 (2018).","journal-title":"J Acad Nutr Diet."},{"issue":"1","key":"88420_CR33","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","volume":"8","author":"HE Da Silva","year":"2018","unstructured":"Da Silva, H. E. et al. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. Sci. Rep. 8(1), 1466 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"88420_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","volume":"20","author":"F Li","year":"2021","unstructured":"Li, F., Ye, J., Shao, C. & Zhong, B. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. Lipids Health Dis. 20(1), 22 (2021).","journal-title":"Lipids Health Dis."},{"key":"88420_CR35","doi-asserted-by":"publisher","first-page":"1110536","DOI":"10.3389\/fnut.2023.1110536","volume":"10","author":"M Maestri","year":"2023","unstructured":"Maestri, M., Santopaolo, F., Pompili, M., Gasbarrini, A. & Ponziani, F. R. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies. Front Nutr. 10, 1110536 (2023).","journal-title":"Front Nutr."},{"issue":"9","key":"88420_CR36","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/nu14091773","volume":"14","author":"FM Calabrese","year":"2022","unstructured":"Calabrese, F. M. et al. A low glycemic index mediterranean diet combined with aerobic physical activity rearranges the gut microbiota signature in NAFLD patients. Nutrients. 14(9), 1773 (2022).","journal-title":"Nutrients."},{"issue":"4","key":"88420_CR37","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/nu10040448","volume":"10","author":"D Gille","year":"2018","unstructured":"Gille, D., Schmid, A., Walther, B. & Verg\u00e8res, G. Fermented food and non-communicable chronic diseases: A review. Nutrients. 10(4), 448 (2018).","journal-title":"Nutrients."},{"issue":"3","key":"88420_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ejcn.2009.145","volume":"64","author":"P Mullie","year":"2010","unstructured":"Mullie, P., Clarys, P., Hulens, M. & Vansant, G. Dietary patterns and socioeconomic position. Eur. J. Clin. Nutr. 64(3), 231\u2013238 (2010).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"88420_CR39","first-page":"274","volume":"27","author":"HP Fransen","year":"2017","unstructured":"Fransen, H. P. et al. Associations between lifestyle factors and an unhealthy diet. Eur. J. Public Health. 27(2), 274\u2013278 (2017).","journal-title":"Eur. J. Public Health."},{"issue":"10","key":"88420_CR40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2468-1253(23)00206-6","volume":"8","author":"M Israelsen","year":"2023","unstructured":"Israelsen, M., Torp, N., Johansen, S., Thiele, M. & Krag, A. MetALD: New opportunities to understand the role of alcohol in steatotic liver disease. Lancet Gastroenterol. Hepatol. 8(10), 866\u2013868 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"37","key":"88420_CR41","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.3748\/wjg.v27.i37.6161","volume":"27","author":"SP Sharma","year":"2021","unstructured":"Sharma, S. P., Suk, K. T. & Kim, D. J. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J. Gastroenterol. 27(37), 6161\u20136179 (2021).","journal-title":"World J. Gastroenterol."},{"issue":"42","key":"88420_CR42","doi-asserted-by":"publisher","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","volume":"111","author":"S Leclercq","year":"2014","unstructured":"Leclercq, S. et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. U S A. 111(42), E4485\u2013E4493 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"88420_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.990953","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Emerging trends and hotspots in the links between the gut microbiota and MAFLD from 2002 to 2021: A bibliometric analysis. Front. Endocrinol. (Lausanne). 13, 990953 (2022).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"88420_CR44","first-page":"397","volume":"156","author":"H El Enshasy","year":"2016","unstructured":"El Enshasy, H. et al. Anaerobic probiotics: The key microbes for human health. Adv. Biochem. Eng. Biotechnol. 156, 397\u2013431 (2016).","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"issue":"4","key":"88420_CR45","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","volume":"76","author":"M Demir","year":"2022","unstructured":"Demir, M. et al. The fecal mycobiome in non-alcoholic fatty liver disease. J Hepatol. 76(4), 788\u2013799 (2022).","journal-title":"J Hepatol."},{"key":"88420_CR46","doi-asserted-by":"crossref","unstructured":"Lanthier N, Delzenne N. Targeting the gut microbiome to treat metabolic dysfunction-associated fatty liver disease: Ready for prime time? Cells. 11(17). (2022)","DOI":"10.3390\/cells11172718"},{"issue":"8","key":"88420_CR47","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","volume":"76","author":"Z Safari","year":"2019","unstructured":"Safari, Z. & G\u00e9rard, P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol. Life Sci. 76(8), 1541\u20131558 (2019).","journal-title":"Cell Mol. Life Sci."},{"issue":"7","key":"88420_CR48","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1007\/s00394-021-02572-6","volume":"60","author":"P Day-Walsh","year":"2021","unstructured":"Day-Walsh, P. et al. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota. Eur. J. Nutr. 60(7), 3987\u20133999 (2021).","journal-title":"Eur. J. Nutr."},{"issue":"10","key":"88420_CR49","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1177\/2050640618804444","volume":"6","author":"M Rau","year":"2018","unstructured":"Rau, M. et al. Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. United European Gastroenterol. J. 6(10), 1496\u20131507 (2018).","journal-title":"United European Gastroenterol. J."},{"issue":"4","key":"88420_CR50","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","volume":"30","author":"J Yuan","year":"2019","unstructured":"Yuan, J. et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab. 30(4), 675\u201388.e7 (2019).","journal-title":"Cell Metab."},{"issue":"7","key":"88420_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2022.101997","volume":"46","author":"A Sourianarayanane","year":"2022","unstructured":"Sourianarayanane, A. & McCullough, A. J. Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis. Clin. Res. Hepatol. Gastroenterol. 46(7), 101997 (2022).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"88420_CR52","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021;75(3):659\u201389.","DOI":"10.1016\/j.jhep.2021.05.025"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88420-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88420-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88420-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T08:47:42Z","timestamp":1739609262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88420-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88420"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88420-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocols of the NHANES were approved by the National Center for Health Statistics institutional review board, with all individuals providing informed written consent. Human study considerations were exempted due to the anonymity of the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5595"}}